Cargando…

Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

Detalles Bibliográficos
Autores principales:	Venturelli, Sascha, Berger, Alexander, Böcker, Alexander, Busch, Christian, Weiland, Timo, Noor, Seema, Leischner, Christian, Schleicher, Sabine, Mayer, Mascha, Weiss, Thomas S., Bischoff, Stephan C., Lauer, Ulrich M., Bitzer, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765455/ http://dx.doi.org/10.1371/annotation/5b9a8614-1009-40ca-b90b-db817fe445c9

Ejemplares similares

Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
por: Venturelli, Sascha, et al.
Publicado: (2013)

Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma
por: Mayer, Mascha, et al.
Publicado: (2022)

Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment
por: Leischner, Christian, et al.
Publicado: (2016)

Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials
por: Renner, Olga, et al.
Publicado: (2022)

Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status
por: Leischner, Christian, et al.
Publicado: (2021)

Epigenetic activities of flavonoids in the prevention and treatment of cancer
por: Busch, Christian, et al.
Publicado: (2015)

Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells
por: Venturelli, Sascha, et al.
Publicado: (2014)

Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo
por: Niessner, Heike, et al.
Publicado: (2022)

Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model
por: Lauer, Annie, et al.
Publicado: (2021)

High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma
por: Burkard, Markus, et al.
Publicado: (2023)

Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
por: Jeong, Hyeanjeong, et al.
Publicado: (2019)

Protein Acetylation and the Physiological Role of HDACs
por: Matthias, Patrick, et al.
Publicado: (2011)

Potential Protective Protein Components of Cow’s Milk against Certain Tumor Entities
por: Leischner, Christian, et al.
Publicado: (2021)

Vitamins as Possible Cancer Biomarkers: Significance and Limitations
por: Venturelli, Sascha, et al.
Publicado: (2021)

Minerals and Cancer: Overview of the Possible Diagnostic Value
por: Venturelli, Sascha, et al.
Publicado: (2022)

Selective Protection of Human Liver Tissue in TNF-Targeting of Cancers of the Liver by Transient Depletion of Adenosine Triphosphate
por: Weiland, Timo, et al.
Publicado: (2012)

Vitamin C Deficiency in Blood Samples of COVID-19 Patients
por: Sinnberg, Tobias, et al.
Publicado: (2022)

Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in Cancer
por: Leischner, Christian, et al.
Publicado: (2023)

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
por: Urias, Beatriz Silva, et al.
Publicado: (2022)

Host histone acetylation unlocks HDAC inhibitor potential
por: Terranova-Barberio, Manuela, et al.
Publicado: (2017)

Hepatoblastoma—The Evolution of Biology, Surgery, and Transplantation
por: Lim, Irene Isabel P., et al.
Publicado: (2018)

‘Teratoid’ Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma
por: Sergi, Consolato M., et al.
Publicado: (2022)

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
por: Pasricha, Sant-Rayn, et al.
Publicado: (2017)

HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
por: Wang, Jie, et al.
Publicado: (2022)

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
por: Bandolik, Jan J., et al.
Publicado: (2019)

Bromodomains shake the hegemony of pan-acetyl antibodies
por: Champleboux, Morgane, et al.
Publicado: (2015)

Hepatoblastoma : presentación de un caso clínico /
por: Mora Sarmiento, Laura
Publicado: (1988)

Characterizing HDAC Pathway Copy Number Variation in Pan-Cancer
por: Yang, Shuming, et al.
Publicado: (2022)

The ROS-induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF-1alpha in the NCI60 cancer cell lines
por: Sinnberg, Tobias, et al.
Publicado: (2014)

Hepatoblastoma: when to screen?
por: O’Malley, Margaret, et al.
Publicado: (2011)

Hepatoblastoma with Precocious Puberty
por: Yhoshu, Enono, et al.
Publicado: (2019)

The Genetic Changes of Hepatoblastoma
por: Chen, Huitong, et al.
Publicado: (2021)

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma
por: Armeanu-Ebinger, Sorin, et al.
Publicado: (2013)

Differential Methylation and Acetylation as the Epigenetic Basis of Resveratrol’s Anticancer Activity
por: Farhan, Mohd, et al.
Publicado: (2019)

Resveratrol inhibits ACHN cells via regulation of histone acetylation
por: Dai, Lili, et al.
Publicado: (2020)

Physical and Functional HAT/HDAC Interplay Regulates Protein Acetylation Balance
por: Peserico, Alessia, et al.
Publicado: (2011)

HDAC5-Mediated Acetylation of p100 Suppresses Its Processing
por: Wang, Jianqi, et al.
Publicado: (2022)

Dietary Compound Resveratrol Is a Pan-BET Bromodomain Inhibitor
por: Dutra, Luiz Antonio, et al.
Publicado: (2017)

An Alternative Strategy for Pan-acetyl-lysine Antibody Generation
por: Kim, Sun-Yee, et al.
Publicado: (2016)

Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge
por: Moll, Alexander, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2niqbh8d3p479qrboalikhe1d7